Tesamorelin + Ipamorelin

Handling & storage

Tesamorelin + Ipamorelin is a dual-peptide research formulation supplied for controlled laboratory and analytical investigation involving endocrine signaling, receptor pharmacology, peptide-receptor interactions, and downstream cellular pathways. The formulation combines two structurally and pharmacologically distinct research peptides, providing a model for studying multiple receptor-mediated signaling mechanisms within a defined experimental system. Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) and is investigated in laboratory models involving GHRH receptor activation and associated endocrine signaling. Ipamorelin is a synthetic pentapeptide investigated for its interaction with the growth hormone secretagogue receptor (GHSR). Because these peptides are associated with distinct receptor systems, the combination may be used experimentally to examine their respective and interacting signaling pathways. Research involving Tesamorelin or Ipamorelin individually should be distinguished from research involving the complete Tesamorelin + Ipamorelin formulation. Findings associated with either individual peptide do not automatically establish the biological activity, safety, or characteristics of the combined formulation. For research use only. Keep lyophilized material protected from light, moisture, and temperature excursions. Follow institutional SOPs, product documentation, and the applicable Certificate of Analysis for storage, handling, preparation, and disposal. Not for human or veterinary consumption or administration. Not intended for weight management, body-composition modification, performance enhancement, anti-aging, diagnostic, therapeutic, or clinical use.